Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion type Assertion NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_head.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion description "[Therefore, careful monitoring of urinary Ca excretion before and during treatment of PTH-deficient hypoparathyroidism is very important, and screening of CaSR mutation should be considered in patients with relative hypercalciuria or with a family history of hypocalcemia.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion evidence source_evidence_literature NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion SIO_000772 12733714 NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion wasDerivedFrom befree-2016 NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.
- NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_assertion wasGeneratedBy ECO_0000203 NP393396.RAZLlQBTFDnO05nAOLynsi0wCWHWeMC-Xy3pvueYJhxfQ130_provenance.